|
Volumn 29, Issue 5, 2011, Pages 373-374
|
PARP inhibitors stumble in breast cancer.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
DACARBAZINE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
TEMOZOLOMIDE;
ALLELE;
BREAST TUMOR;
CLINICAL TRIAL (TOPIC);
DNA DAMAGE;
DNA REPAIR;
DRUG ANTAGONISM;
ENZYMOLOGY;
FEMALE;
HUMAN;
NOTE;
TUMOR SUPPRESSOR GENE;
ALLELES;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BREAST NEOPLASMS;
CLINICAL TRIALS AS TOPIC;
DACARBAZINE;
DNA DAMAGE;
DNA REPAIR;
ENZYME INHIBITORS;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
HUMANS;
POLY(ADP-RIBOSE) POLYMERASES;
|
EID: 80052535308
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0511-373 Document Type: Note |
Times cited : (96)
|
References (0)
|